The best choice depends on current weight and BMI, weight-related medical conditions, blood sugar status, cardiovascular risk, liver health, kidney function, medication history, side-effect risk, muscle mass and nutrition status, cost and access, patient preference, and long-term maintenance planning
Exploring Glucagon-like Peptide-1 receptor agonist (GLP-1 RA) Use in Patients with Cirrhosis Kimmy Nguyen Jul 2, 2025 4 min read Written by Braylee Wardwell, PharmD and Marissa Salvo, PharmD, BCACP, FCPA, FCCP What is Cirrhosis
Compared with HD, CKRT results in fewer cardiovascular complications, less need for plasma and blood transfusions, and a lower risk of rebound hyperammonaemia 34,36,39
Conclusion - Protein Isnt the Problem Poor Protein Choices Are Most people blame protein itself when they experience bloating
Sometimes a moderate capacity with a higher C-rating is better than a huge capacity with a lower rating